Actively Recruiting

All Genders
NCT07254117

The Role of Granulation Tissue in Periodontal Regeneration

Led by Riga Stradins University · Updated on 2025-11-28

46

Participants Needed

1

Research Sites

65 weeks

Total Duration

On this page

Sponsors

R

Riga Stradins University

Lead Sponsor

U

University of Turku

Collaborating Sponsor

AI-Summary

What this Trial Is About

The goal of this observational study is to distinguish the infectious, healing, and regeneration-related characteristics of two types of gingival granulation tissues, namely infra-osseous and supra-osseous granulation tissues, in people with severe periodontitis (gum disease). Researchers aim to denote if these tissues may play role in healing after periodontal treatment. Researchers will also compare smokers and non-smokers to see if smoking disrupts the healing potential or infectious properties of granulation tissue. Participants will provide gingival fluid (before) and granulation tissue samples (at the time of) periodontal surgery. The main questions this study aims to answer are: 1. Do infra- and supra-osseous granulation tissues have different healing potential and infectious properties? 2. How do these tissues differ in people who smoke compared to people who do not smoke?

CONDITIONS

Official Title

The Role of Granulation Tissue in Periodontal Regeneration

Who Can Participate

All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Both genders
  • Systemically healthy
  • Smokers (smoking at least 10 cigarettes a day or electronic cigarettes daily or quit less than 5 years ago) and non-smokers (never smoked, smoke no more than once a month, or quit at least 5 years ago)
  • Aged 18 years and over
  • History of severe periodontitis (Stage III or IV, Grade B or C) with at least one vertical bone defect (≥3 mm infrabony component) in premolar-molar area after non-surgical treatment
  • Plaque index and bleeding on probing of 20% or lower before surgery
Not Eligible

You will not qualify if you...

  • Systemic diseases affecting study results (uncontrolled type 2 diabetes with HbA1c >7%, recent myocardial infarction or stroke within 6 months, blood coagulation disorders)
  • Use of medications affecting study results (anti-osteoporotic drugs, statins, corticosteroids, calcium channel blockers, cyclosporine A, antiepileptics, antipsychotics, antidepressants, chemotherapy or radiotherapy)
  • Current pregnancy or breastfeeding
  • Use of systemic antibiotics within 6 months before study
  • Need for antibiotic premedication before periodontal treatment
  • Prosthetic factors on teeth with bone defects preventing clinical measurements
  • Lack of motivation for proper dental care or to complete periodontal treatment
  • Strong vomiting reflex preventing adequate periodontal treatment

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Riga Stradins University Institute of Stomatology

Riga, Latvia, LV-1013

Actively Recruiting

Loading map...

Research Team

D

Dārta E Emuliņa, DDS

CONTACT

How is the study designed?

Study Type

OBSERVATIONAL

Masking

N/A

Allocation

N/A

Model

N/A

Primary Purpose

N/A

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here